tradingkey.logo
搜尋

Rxsight Inc

RXST
添加自選
6.105USD
+0.085+1.41%
收盤 09-14 16:00美東
253.67M總市值
虧損本益比TTM

關於 Rxsight Inc 公司

RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.

Rxsight Inc 簡介

公司代碼RXST
公司名稱Rxsight Inc
上市日期Jul 30, 2021
CEOKurtz (Ron M)
員工數量498
證券類型Ordinary Share
年結日Jul 30
公司地址100 Columbia Street
城市ALISO VIEJO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編92656
電話19495217822
網址https://www.rxsight.com/
公司代碼RXST
上市日期Jul 30, 2021
CEOKurtz (Ron M)

Rxsight Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Business Development Officer
Co-President, Chief Business Development Officer
501.25K
-0.41%
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Business Development Officer
Co-President, Chief Business Development Officer
501.25K
-0.41%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Chief Operating Officer
Chief Operating Officer
82.88K
-2.46%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Chief Operating Officer
Chief Operating Officer
82.88K
-2.46%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
78.08K
+47.44%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
78.08K
+47.44%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
55.17K
+67.13%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
55.17K
+67.13%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Business Development Officer
Co-President, Chief Business Development Officer
501.25K
-0.41%
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Business Development Officer
Co-President, Chief Business Development Officer
501.25K
-0.41%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Chief Operating Officer
Chief Operating Officer
82.88K
-2.46%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Chief Operating Officer
Chief Operating Officer
82.88K
-2.46%

常見問題

Rxsight Inc的前五大股東是誰?

Rxsight Inc的前五大股東如下:Mr. Eric Weinberg

有多少機構持有Rxsight Inc(RXST)的股份?

截至2026Q1,共有467家機構持有Rxsight Inc的股份,合計持有的股份價值約為38.60M,占公司總股份的93.24% 。與2025Q4相比,機構持股有所增加,增幅為-10991579.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有